TrialHuman gene therapy2014

Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy.

Valerie Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.